Literature DB >> 16507409

Detection of epithelial cell death in the body by cytokeratin 18 measurement.

T Ueno1, M Toi, S Linder.   

Abstract

Cell death is as important as cell division in both physiological and pathological processes. Three major types of cell death have been described: apoptosis, autophagy and necrosis. Apoptosis is a form of programmed cell death, mediated by caspases. Autophagy is an evolutionarily conserved process involving lysosomes, implicated in both cell survival and death. Necrosis is believed to be an unregulated process, followed by release of intracellular components. The epithelial-specific intermediate filament cytokeratin 18 (Kl8) has different fates depending on the type of cell death. During apoptosis, K18 is cleaved at two sites into three fragments, one of which is specifically recognized by the monoclonal antibody, M30. During autophagy K18 is reported to stay uncleaved. Necrotic cells are considered to release K18. Thus, serum levels of different forms of K18 would reflect the type of cell death occurring in the body. Two enzyme-linked immunosorbent assays have been developed: one for the cleaved fragments of K18 and the other for total K18. Detection of serum levels of cleaved and total K18 showed that the ratios between cleaved and total K18 were highly variable among patients with endometrial cancer. Monitoring serum levels of cleaved and total K18 during chemotherapy showed an association between increases in total K18 levels and clinical responses. Monitoring serum levels of K18 may be a promising approach for early detection of therapeutic effects and the levels of different forms of K18 might indicate the mode of cell death occurring in the body.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16507409     DOI: 10.1016/s0753-3322(05)80078-2

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  29 in total

1.  M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes.

Authors:  Fataneh Amidi; Barbara A French; David Chung; Charles H Halsted; Valentina Medici; Samuel W French
Journal:  Exp Mol Pathol       Date:  2007-10-25       Impact factor: 3.362

2.  Investigation of JAKs/STAT-3 in lipopolysaccharide-induced intestinal epithelial cells.

Authors:  L Fu; L-W Wei; M-D Zhao; J-L Zhu; S-Y Chen; X-B Jia; S-J Lai
Journal:  Clin Exp Immunol       Date:  2016-08-01       Impact factor: 4.330

3.  The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.

Authors:  Buse Cevatemre; Engin Ulukaya; Mehmet Sarimahmut; Arzu Yilmaztepe Oral; Fiona M Frame
Journal:  Tumour Biol       Date:  2015-04-07

4.  Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Su-Jun Zheng; Shuang Liu; Mei Liu; Malcolm A McCrae; Jun-Feng Li; Yuan-Ping Han; Chun-Hui Xu; Feng Ren; Yu Chen; Zhong-Ping Duan
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.

Authors:  Sandrine J Faivre; Anthony J Olszanski; Karin Weigang-Köhler; Hanno Riess; Roger B Cohen; Xuejing Wang; Scott P Myrand; Enaksha R Wickremsinhe; Candice L Horn; Haojun Ouyang; Sophie Callies; Karim A Benhadji; Eric Raymond
Journal:  Invest New Drugs       Date:  2015-09-16       Impact factor: 3.850

6.  The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.

Authors:  Ahmet Bilici; Bala Basak Oven Ustaalioglu; Serif Ercan; Mesut Seker; Burcak Erkol Yilmaz; Asuman Orcun; Mahmut Gumus
Journal:  Tumour Biol       Date:  2012-08-14

7.  The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

Authors:  Bala Basak Oven Ustaalioglu; Ahmet Bilici; Serif Ercan; Mesut Seker; Asuman Orcun; Mahmut Gumus
Journal:  Med Oncol       Date:  2013-03-28       Impact factor: 3.064

8.  M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.

Authors:  T Chu; L Jiang; W Ying; B Han
Journal:  Clin Transl Oncol       Date:  2016-07-28       Impact factor: 3.405

9.  Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis.

Authors:  A Gonzalez-Quintela; I Abdulkader; J Campos; L Fernandez-Hernandez; S Lojo
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

10.  Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.

Authors:  Mitsuteru Kitade; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Kosuke Kaji; Yusaku Shirai; Masaharu Yamazaki; Masahito Uemura; Junichi Yamao; Masao Fujimoto; Akira Mitoro; Masahisa Toyohara; Masayoshi Sawai; Motoyuki Yoshida; Chie Morioka; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.